Product Description
We are engages in proffering Biomab injection that interferes with cancer cell growth and division. Biomab Injection manufactured by Biocon and contains active ingredient Nimotuzumab in it. Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor (EGFR).